Royalty Pharma, Northwestern U, Sloan-Kettering, Amgen, Addrenex Pharmaceuticals, U of Nebraska Med, UTEK Corporation, Pharmalicensing, Hebrew U, Nanolymf, Viral Genetics, U of Colorado, V-Clip Pharmaceuticals, Genocea Biosciences, Harvard Med, Emory U, O | GenomeWeb
Royalty Pharma Buys Portion of NWU’s Royalty Interest in Lyrica for $700M
 
Royalty Pharma and Northwestern University said this month that Northwestern has sold an undisclosed portion of its royalty interest in Lyrica to Royalty Pharma for $700 million in cash.
 
The one-time payment is considered one of the largest royalty monetization deals ever related to an invention spawned from university research.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.